Navigation Links
Gut research yields new anti-cancer approach

Researchers believe they have discovered by chance a new way to fight colorectal cancer, and potentially cancers of the esophagus, liver and skin. Early work shows that a group of compounds called peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibitors may have an unexpected cancer-fighting effect, according to research published today in the journal International Cancer Research. Furthermore, the new studies suggest that PPARgamma inhibitors act through some of the same mechanisms as the blockbuster chemotherapy Taxol, but with key differences.

While studying whether compounds known to affect PPARgamma could play a role in inflammatory bowel diseases, a team at the University of Rochester Medical Center found that medium-to-high doses of PPARgamma inhibitor killed colorectal cancer cell lines. Despite the compound's class name, the anti-cancer effect has nothing to do with the ability of the compounds to inhibit PPARgamma function. Researchers believe that PPARgamma inhibitors instead attack the "skeletons" of cancer cells that enable them to reproduce, grow and spread. Better solutions are needed because, according to the American Cancer Society, colorectal cancer remains the no. 2 cause of cancer death for men, and the no. 3 cause of cancer death for women.

"This is the first observation of a small molecule dramatically reducing levels of the proteins called tubulins, the building blocks of cancer cell skeletons," said Katherine L. Schaefer, Ph.D., a research assistant professor within the Department of Medicine, Gastroenterology and Hepatology Division, at the University of Rochester Medical Center, and first author of the paper. "Because cells that line the colon are similar to those in the liver, esophagus and skin, we see potential for a new way to treat those cancers as well."

In the study that led to the discovery of the anti-cancer effect, researchers were looking for new ways to reduce inflammation seen in Crohn'
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3 4

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. U of M researcher examines newly emerging deadly disease
3. NYU researchers simulate molecular biological clock
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. New research questions basic tenet of neuron function
6. Vital step in cellular migration described by UCSD medical researchers
7. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
8. UCSD researchers maintain stem cells without contaminated animal feeder layers
9. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
10. New protein discovered by Hebrew University researchers
11. First real-time view of developing neurons reveals surprises, say Stanford researchers

Post Your Comments:
(Date:11/24/2009)...ntarctica has long held secrets of the earth,s his... there has been very little information on the env...ce for millions of years. Now, a team of researche...n funded to the tune of $10 million dollars by the...e bottom of things literally. These scientists wi...
(Date:11/23/2009)... The community-associated strain of the deadly su... to most common antibioticsposes a far greater hea... way into hospitals, according to a study in the D..., The new threat is easily picked up in fitness ...increased the overall burden of MRSA within hospit...
(Date:11/23/2009)...Current research suggests that a common oral bacte...ed report by Nichols et al, "Unique Lipids from a ...R2 Ligands Capable of Enhancing Autoimmunity," app...ournal of Pathology . , Multiple sclerosis (MS),...in and spinal cord, affects nearly 1 in 700 people...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Authentidate Holding Corp to Report Fourth Quarter and Fiscal Year End 2009 Results on Thursday September 24 2009 56739 1Authentidate Holding Corp to Report Fourth Quarter and Fiscal Year End 2009 Results on Thursday September 24 2009 56739 2Abaxis Inc to Present at the ThinkEquity Sixth Annual Growth Conference 56737 1PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 1PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 2PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 3PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 4PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 5PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 6
...e and then presented with a chemoattractant signal... a polarized morphology and aggregate to form a mi...pmental program that culminates in the formation o...w this streaming response is coordinated at a sing... Journal of Cell Biology ( www.jcb.org ). , Bes...
... chest wall deformity known as pectus excavatum co...exercise, according to a study published December ...ed at 11 North American hospitals, involved teleph...he ages of 8 and 21 who had pectus excavatum surge...he results were dramatic. Patients reported greatl...
...ant that has a potent effect on gene activity, cou...n the December issue of BioScience . The chemical...d and textile preservative, and as a pesticide on ...ns. , Tributyltin affects sensitive receptors in ...at very low concentrationsa thousand times lower t...
Other Biology News:Marked improvement in body image, physical stamina, post-surgical pectus patients report 2Marked improvement in body image, physical stamina, post-surgical pectus patients report 3Persistent pollutant may promote obesity 2
(Date:11/24/2009)..., SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twomorep...enation,sleadingonlinejobboardandcareerssiteforlif...iaUniversityarenowmembersofthejobboard,joining28ot...jobboard, www.biocareercenter.com ,isonlyforpost-g...ifesciencecareersitesontheInternet,BioCareerCenter...
(Date:11/24/2009)... Health care employment gr...s the only one to show consistent growth during th...ospitals remain in trouble, and health systems are...ersonnel, instead of just administrators. , ...alth care employment continued growing in October ...
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBio...ration(SFDA)hasapprovedthe,investigationalnewdruga...ninnovativeinsulinformulationtotreatdiabetes.ThisI...inicalstudy. , Diabetesisadisordercharacteris...ationsofdiabetesoftenresultinseveremicro-and,macro...
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswi...lyCalottoCapitalInc.,aleadingproviderofadvancedlas...rtilityclinicmarkets,todayreportedoperationalandfi...009. , ,Q32009Highlights,-Revenuewas$1.46million...nwas66.3percentcomparedwith66.1percentinQ3,2008,-N...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...any health plans are moving to in-source Disease M... costs and improve member outcomes , , , ,...nagement Solution(IHMS) platform fully integrates ... , , , , , , Blue Cross Blue Shi...to improve care and manage members, healthcare mor...
...., Feb. 2 MannKind Corporation (Nasdaq: MNKD ),...izing treatments for diabetes and cancer, announce...otechnology Industry Organization BIO CEO & In...:15 PM (EST) at the Hilton Waldorf Astoria in New ... Company will host a breakfast meeting for invited...
...ruary 2 Axentis Pharma AG is to present its,recen...apeutic formulation,for treating chronic lung dise...rum in Zurich, Switzerland. This invited talk come...present its recent achievements at the Biotech,Sho...any,s ongoing success,story is a recent capital in...
Other Biology Technology:Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs 2Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs 3Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs 4MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference 2Chronic Lung Disease - Axentis Pharma Attracts Investment Interest 2Chronic Lung Disease - Axentis Pharma Attracts Investment Interest 3
Newborn Calf Serum from Lifeblood Medical, Inc.
Normal Calf Serum from Equitech-Bio
Custom DNA Primers from Invitrogen
Direct ELISA Assay Diluent from BioFX Laboratories, Inc.
Biology Products: